Endo Pharma

SUPPRELIN LA

  1. Home
  2.  / 
  3. J Code
  4.  / SUPPRELIN LA – J9226

Manufacturer:

Endo Pharma

Name:

SUPPRELIN LA

HCPCS Code Descriptor:

Histrelin implant (supprelin la), 50 mg

Category:

J Code

HCPCS:

J9226

NDC(s):

67979-0002-01

Primary Type:

Growth Disorder

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

SUPPRELIN LA is a Growth Disorder drug manufactured by Endo Pharma and administered via the Subcutaneous route of administration. The J Code: J9226 is aligned to the drug SUPPRELIN LA.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/08

HCPCS Effective Date:

1/1/23

HCPCS Short Description:

Supprelin la implant

Billing and Coding Guide:

https://www.supprelinla.com/pdfs/Surgeon_MVA_Download.pdf

Patient Assistance:

http://www.supprelinla.com/support-center-and-savings.aspx

SUPPRELIN LA - J9226